PMID- 17048575 OWN - NLM STAT- MEDLINE DCOM- 20070912 LR - 20181201 IS - 1001-5302 (Print) IS - 1001-5302 (Linking) VI - 31 IP - 15 DP - 2006 Aug TI - [Mechanism of Shenqi compound recipe anti-earlier diabetic artherosclerosis in GK rats]. PG - 1272-6 AB - OBJECTIVE: To explore the mechanism of Shenqi compound recipe (SQCR) anti-earlier diabetic artherosclerosis in GK rats. METHOD: Four-month specefic pathogen free (SPF) GK rats were divided randomly according to blood glucose level into four groups: model group (5 mL x kg(-1) x d(-1) sterile water), ramipril group (positive control, 1 mg x kg(-1) x d(-1)), SQCR low dosage (0.72 g x kg(-1) x d(-1)) and SQCR high dosage group (2.88 g x kg(-1) x d(-1)) and Wistar rats as normal control group(5 mL x kg(-1) x d(-1) sterile water). GK rats took high-fat diet freely and meanwile were injected N-omega-nitro-L-arginine methyl ester (L-N-AME) intra-peritoneally with the dose of 10 mg x kg(-1) x d(-1) in order to induce earlier diabetic artherosclerosis, while normal control group took regular diet and were injected normal saline intra-peritoneally. In the experiment periods, each group was administrated correspondent substance respectively for 32 d. At the end, sampling blood by abdominal aorta and picking aorta on ice. Determined monocyte chemoattractant protein-1 (MCP-1) concentration by ELISA, messenger ribonucleic acid (mRNA) expression of MCP-1 and peroxisome proliferator-activated receptor gamma (PPARgamma) in aorta by reverse transcriptase PCR (RT-PCR). RESULT: Concentrations of MCP-1 in serum in SQCR low and high dosage groups and the mRNA expression of MCP-1 in SQCR high dosage group were all decreased significantly compared with model group (P < 0.05). The mRNA expression of PPARgamma in SQCR low and high dosage groups all increased compared with model group (P < 0.05 or P < 0.01). CONCLUSION: Inhibiting the mRNA and protein expression of MCP-1 and upregulating the mRNA expression of PPARgamma in aorta might be contribute to SQCR anti-earlier diabetic artherosclerosis in GK rats partly. FAU - Zhang, Hong-min AU - Zhang HM AD - Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu. FAU - Chen, Shi-wei AU - Chen SW FAU - Xie, Chun-guang AU - Xie CG FAU - Xie, Yi-qiang AU - Xie YQ FAU - Deng, Xi-fang AU - Deng XF LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhongguo Zhong Yao Za Zhi JT - Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica JID - 8913656 RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Drug Combinations) RN - 0 (Drugs, Chinese Herbal) RN - 0 (PPAR gamma) RN - 0 (RNA, Messenger) SB - IM MH - Animals MH - Aorta/metabolism MH - Astragalus propinquus/chemistry MH - Atherosclerosis/etiology/*metabolism MH - Chemokine CCL2/*biosynthesis/blood/genetics MH - Diabetes Mellitus, Type 2/complications/*metabolism MH - Drug Combinations MH - Drugs, Chinese Herbal/isolation & purification/*pharmacology MH - Male MH - PPAR gamma/biosynthesis/genetics MH - Panax/chemistry MH - *Plants, Medicinal/chemistry MH - RNA, Messenger/biosynthesis/genetics MH - Random Allocation MH - Rats MH - Rats, Wistar EDAT- 2006/10/20 09:00 MHDA- 2007/09/13 09:00 CRDT- 2006/10/20 09:00 PHST- 2006/10/20 09:00 [pubmed] PHST- 2007/09/13 09:00 [medline] PHST- 2006/10/20 09:00 [entrez] PST - ppublish SO - Zhongguo Zhong Yao Za Zhi. 2006 Aug;31(15):1272-6.